Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
13.5 SEK | +2.66% | +16.38% | +69.81% |
04-25 | Arcoma AB Reports Earnings Results for the First Quarter Ended March 31, 2024 | CI |
01-29 | Arcoma AB Reports Earnings Results for the Full Year Ended December 31, 2023 | CI |
Sales 2024 * | 183M 16.78M 1.34B | Sales 2025 * | 199M 18.25M 1.46B | Capitalization | 178M 16.32M 1.3B |
---|---|---|---|---|---|
Net income 2024 * | 14M 1.28M 103M | Net income 2025 * | 16M 1.47M 117M | EV / Sales 2024 * | 0.93 x |
Net cash position 2024 * | 7M 642K 51.3M | Net cash position 2025 * | 19M 1.74M 139M | EV / Sales 2025 * | 0.8 x |
P/E ratio 2024 * |
13.1
x | P/E ratio 2025 * |
11.2
x | Employees | 31 |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 53.16% |
1 day | +2.66% | ||
1 week | +16.38% | ||
Current month | +13.45% | ||
1 month | +13.45% | ||
3 months | +66.67% | ||
6 months | +76.47% | ||
Current year | +69.81% |
Managers | Title | Age | Since |
---|---|---|---|
Johan Dahlberg
DFI | Director of Finance/CFO | 40 | 31/12/21 |
Chief Tech/Sci/R&D Officer | 53 | 31/12/13 |
Members of the board | Title | Age | Since |
---|---|---|---|
Director/Board Member | 57 | - | |
Director/Board Member | 53 | 28/02/10 | |
Lars Kvarnhem
CHM | Chairman | 52 | 31/12/16 |
Date | Price | Change | Volume |
---|---|---|---|
26/04/24 | 13.5 | +2.66% | 103,388 |
25/04/24 | 13.15 | +12.88% | 363,784 |
24/04/24 | 11.65 | -2.10% | 49,419 |
23/04/24 | 11.9 | -0.83% | 10,220 |
22/04/24 | 12 | +3.45% | 28,564 |
Delayed Quote Nasdaq Stockholm, April 26, 2024 at 04:29 pm
More quotesEPS Revisions
Annual profits - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
+69.81% | 16.24M | |
-5.77% | 14.68B | |
-40.71% | 2.71B | |
-12.92% | 2.44B | |
-8.78% | 1.51B | |
-.--% | 1.12B | |
+40.66% | 518M | |
+11.68% | 239M | |
+1.67% | 183M | |
-.--% | 168M |
- Stock Market
- Equities
- ARCOMA Stock